Hillsdale Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-43,200
Closed -$2.47M 587
2020
Q1
$2.47M Sell
43,200
-200
-0.5% -$18.4K 0.3% 101
2019
Q4
$4.85M Buy
43,400
+12,300
+40% +$1.31M 0.42% 63
2019
Q3
$2.99M Buy
31,100
+5,800
+23% +$544K 0.26% 117
2019
Q2
$2.17M Hold
25,300
0.21% 105
2019
Q1
$2.1M Sell
25,300
-2,100
-8% -$153K 0.19% 104
2018
Q4
$1.76M Buy
27,400
+7,000
+34% +$479K 0.21% 106
2018
Q3
$1.62M Hold
20,400
0.21% 93
2018
Q2
$1.49M Buy
+20,400
New +$1.39M 0.18% 101

Other funds holding CNMD

Hillsdale Investment Management's CNMD Position: Q2 2020 in Review

Hillsdale Investment Management sold out of CONMED (CNMD) in Q2 2020, closing a stake of 43,200 shares — an estimated $2.47M sold.

Hillsdale Investment Management first reported a position in CNMD in Q2 2018 and held it in 8 quarters. The position peaked at $4.85M in Q4 2019. 227 funds tracked by Wall St. Rank hold CNMD as of Q2 2020.

  • Hillsdale Investment Management reported no remaining CONMED position as of Q2 2020 after selling out during the quarter.
  • Hillsdale Investment Management sold 43,200 CONMED shares in Q2 2020, an estimated $2.47M.
  • Hillsdale Investment Management first reported a position in CONMED in Q2 2018 and held it in 8 quarters.
  • Hillsdale Investment Management's CONMED position peaked at $4.85M in Q4 2019.
  • 227 funds tracked by Wall St. Rank held CONMED as of Q2 2020.

Based on Hillsdale Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.